Christine Mikail Cvijic - Mar 13, 2024 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role: President and CFO
Signature: /s/ Christine Mikail
Stock symbol: NGNE
Transactions as of: Mar 13, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/14/2024, 08:53 PM
Previous filing: Dec 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NGNE	Common Stock	Award	$0	+31.9K	+152.35%	$0.00	52.8K	Mar 13, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NGNE	Employee Stock Option (Right to buy)	Award	$0	+53.9K		$0.00	53.9K	Mar 13, 2024	Common Stock	53.9K	$36.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.